SLQT Shareholders May Lead Class Action Lawsuit Amid Allegations of Medicare Advantage Plan Misconduct
ByAinvest
Monday, Aug 18, 2025 5:57 pm ET1min read
SLQT--
Key Details of the Lawsuits
- Filing Law Firms: Bernstein Liebhard LLP and The Law Offices of Frank R. Cruz have filed separate class action lawsuits on behalf of investors.
- Class Period: The lawsuits cover the period from September 9, 2020 to May 1, 2025.
- Allegations: The complaints allege that SelectQuote, Inc. made materially false and misleading statements, failed to disclose material adverse facts, and engaged in illegal kickbacks from health insurance companies to steer Medicare beneficiaries to certain plans. These actions resulted in investors suffering financial losses.
- Lead Plaintiff Deadline: Investors have until October 10, 2025, to move the court to serve as lead plaintiff in the Bernstein Liebhard LLP lawsuit. For the Law Offices of Frank R. Cruz lawsuit, the deadline is 60 days from the date of the notice.
Impact on SelectQuote, Inc.
Following the filing of the lawsuits and the Department of Justice's False Claims Act complaint, SelectQuote, Inc.'s stock price fell significantly. On May 1, 2025, the stock price decreased by $0.61, or 19.2%, to close at $2.56 per share.
Next Steps for Investors
Investors who purchased SelectQuote, Inc. securities during the specified period are encouraged to review the details of the lawsuits and consider their legal rights. To join the class action lawsuit, visit [Rosen Legal](https://rosenlegal.com/submit-form/?case_id=39510) or call Phillip Kim, Esq. toll-free at 866-767-3653.
References:
[1] https://www.globenewswire.com/news-release/2025/08/18/3134969/0/en/SHAREHOLDER-ALERT-Bernstein-Liebhard-LLP-Announces-A-Securities-Fraud-Class-Action-Lawsuit-Has-Been-Filed-Against-SelectQuote-Inc-NYSE-SLQT.html
[2] https://www.morningstar.com/news/business-wire/20250811153040/slqt-class-action-notice-the-law-offices-of-frank-r-cruz-files-securities-fraud-lawsuit-against-selectquote-inc
[3] https://www.prnewswire.com/news-releases/repl-investors-have-opportunity-to-lead-replimune-group-inc-securities-lawsuit-first-filed-by-the-rosen-law-firm-302530462.html
Investors who purchased SelectQuote, Inc. (NYSE: SLQT) securities between September 9, 2020 and May 1, 2025 may be entitled to compensation due to alleged false and misleading statements made by the company. To join the class action lawsuit, visit rosenlegal.com/submit-form/?case_id=39510 or call Phillip Kim, Esq. at 866-767-3653. A lead plaintiff must move the Court no later than October 10, 2025.
Investors who purchased SelectQuote, Inc. (NYSE: SLQT) securities between September 9, 2020 and May 1, 2025 may be entitled to compensation due to alleged false and misleading statements made by the company. Two separate class action lawsuits have been filed against SelectQuote, Inc., alleging that the company engaged in fraudulent activities and misrepresented its business practices.Key Details of the Lawsuits
- Filing Law Firms: Bernstein Liebhard LLP and The Law Offices of Frank R. Cruz have filed separate class action lawsuits on behalf of investors.
- Class Period: The lawsuits cover the period from September 9, 2020 to May 1, 2025.
- Allegations: The complaints allege that SelectQuote, Inc. made materially false and misleading statements, failed to disclose material adverse facts, and engaged in illegal kickbacks from health insurance companies to steer Medicare beneficiaries to certain plans. These actions resulted in investors suffering financial losses.
- Lead Plaintiff Deadline: Investors have until October 10, 2025, to move the court to serve as lead plaintiff in the Bernstein Liebhard LLP lawsuit. For the Law Offices of Frank R. Cruz lawsuit, the deadline is 60 days from the date of the notice.
Impact on SelectQuote, Inc.
Following the filing of the lawsuits and the Department of Justice's False Claims Act complaint, SelectQuote, Inc.'s stock price fell significantly. On May 1, 2025, the stock price decreased by $0.61, or 19.2%, to close at $2.56 per share.
Next Steps for Investors
Investors who purchased SelectQuote, Inc. securities during the specified period are encouraged to review the details of the lawsuits and consider their legal rights. To join the class action lawsuit, visit [Rosen Legal](https://rosenlegal.com/submit-form/?case_id=39510) or call Phillip Kim, Esq. toll-free at 866-767-3653.
References:
[1] https://www.globenewswire.com/news-release/2025/08/18/3134969/0/en/SHAREHOLDER-ALERT-Bernstein-Liebhard-LLP-Announces-A-Securities-Fraud-Class-Action-Lawsuit-Has-Been-Filed-Against-SelectQuote-Inc-NYSE-SLQT.html
[2] https://www.morningstar.com/news/business-wire/20250811153040/slqt-class-action-notice-the-law-offices-of-frank-r-cruz-files-securities-fraud-lawsuit-against-selectquote-inc
[3] https://www.prnewswire.com/news-releases/repl-investors-have-opportunity-to-lead-replimune-group-inc-securities-lawsuit-first-filed-by-the-rosen-law-firm-302530462.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet